\u00a0<\/p>\n
(EMAILWIRE.COM<\/a>, July 19, 2024 ) InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Centesis Catheters Market Size, Share & Trends Analysis Report By Type (Small-Bore Centesis Catheters and Large-Bore Centesis Catheters), By Procedure (Paracentesis, Thoracentesis, Arthrocentesis, and Amniocentesis), By Application (Diagnostic, Therapeutic, and Palliative Care), By End-User (Hospitals, Ambulatory Surgical Centers, Other End Use)- Market Outlook and Industry Analysis 2031”<\/p>\n Download Free Demo Report: https:\/\/www.insightaceanalytic.com\/request-sample\/1696<\/a> <\/p>\n Centesis catheters serve as essential tools in modern medical procedures, specifically designed for draining excess fluids from various body cavities and organs with minimal invasiveness. They are pivotal in treating conditions such as pleural effusions, ascites, pericardial effusions, and abscesses, where fluid accumulation can lead to serious complications. These catheters are categorized into small-bore and large-bore types, each tailored for specific applications like thoracentesis, paracentesis, pericardiocentesis, and abscess aspiration. Their versatility and effectiveness in fluid management contribute significantly to improving patient comfort and clinical outcomes across diverse medical specialties, including oncology, nephrology, cardiology, and gastroenterology. List of Prominent Players in the Centesis Catheters Market:<\/p>\n \u0095\tAngioDynamics, Inc. (US) Market Dynamics:<\/p>\n Drivers- Challenges: Regional Trends:<\/p>\n North America stands at the forefront of the global centesis catheters market, driven by several key factors. The region benefits from a high prevalence of chronic diseases like cardiovascular diseases and neurovascular conditions, which necessitate frequent centesis procedures. Major players such as AngioDynamics, Avanos Medical, BD, Boston Scientific, Medtronic, and Merit Medical are actively investing in research and development, bolstering adoption rates through innovative catheter designs and robust marketing strategies. Additionally, the supportive regulatory environment in the US and Canada, overseen by agencies like the FDA, streamlines the approval process for new catheter technologies. The growing preference for minimally invasive procedures among North American patients, coupled with the rising popularity of image-guided techniques, further solidifies the region’s leadership in the global centesis catheters market.<\/p>\n Curious about this latest version of the report? @ https:\/\/www.insightaceanalytic.com\/enquiry-before-buying\/1696<\/a> <\/p>\n Recent Developments: Segmentation of Centesis Catheters Market-<\/p>\n By Type- Value (US$ Mn) and Volume (No. of Units): By Procedures- Value (US$ Mn) and Volume (No. of Units): By Application- Value (US$ Mn) and Volume (No. of Units): By End-Use- Value (US$ Mn) and Volume (No. of Units): By Region-![](\"http:\/\/www.emailwire.com\/files\/pr_images\/mid_thumbs\/1_1721299159_1146250.jpg\" "\\"\\"")
<\/a><\/div>\n
\nThe centesis catheters market is poised for robust growth driven by technological advancements in catheter design, increasing prevalence of chronic diseases necessitating fluid drainage procedures, and a growing elderly population susceptible to fluid-related conditions.
\nManufacturers are innovating with features such as integrated valves for enhanced fluid control, improved flow dynamics, and designs focused on maximizing patient safety and procedural efficiency. As these catheters become integral tools in hospitals, ambulatory surgical centers, and specialty clinics, healthcare professionals rely on them to deliver precise and effective fluid management solutions, underscoring their critical role in modern healthcare practice.<\/p>\n
\n\u0095\tARGON MEDICAL
\n\u0095\tAvanos Medical Devices (US)
\n\u0095\tAxiom Medical, Inc. (US)
\n\u0095\tBraun Melsungen AG (Germany)
\n\u0095\tBD
\n\u0095\tBlue Neem Medical Devices Pvt. Ltd. (India)
\n\u0095\tBoston Scientific Corporation
\n\u0095\tBraun SE
\n\u0095\tCanadian Hospital Specialties Ltd. (Canada)
\n\u0095\tCardinal Health (US)
\n\u0095\tCook Medical (US)
\n\u0095\tGalt Medical Corp. (US)
\n\u0095\tGuangzhou Leadgem Medical Device Co., Ltd. (China)
\n\u0095\tKM Medical (US)
\n\u0095\tMedical Components, Inc. (US)
\n\u0095\tMedtronic (Ireland)
\n\u0095\tMerit Medical Systems (US)
\n\u0095\tMermaid Medical A\/S (Denmark)
\n\u0095\tPFM Medical, Inc.
\n\u0095\tRedax S.P.A.
\n\u0095\tRocket Medical Plc
\n\u0095\tTeleflex Incorporated
\n\u0095\tUreSil, LLC.<\/p>\n
\nThe centesis catheters market is experiencing substantial growth driven by the rising prevalence of chronic diseases such as cancer, tuberculosis, kidney failures, cardiovascular disorders, and bladder-related conditions, affecting a significant portion of the global population. For instance, according to the World Health Organization, approximately 1.8 billion people were infected with Mycobacterium tuberculosis in 2022, with 10.6 million new cases reported and 1.3 million deaths due to TB. This increasing disease burden underscores the critical need for effective fluid management solutions provided by centesis catheters.
\nAdditionally, advancements in minimally invasive procedures and the adoption of image-guided techniques are further fueling market expansion. Technological innovations in catheter design and materials, including plastic, nylon, silicon rubber, and polyvinyl chloride (PVC), are enhancing the safety and efficacy of these devices, while growing awareness among healthcare professionals about the benefits of centesis procedures is boosting market demand. Moreover, supportive regulatory landscapes in major markets like the US and Europe are facilitating the development, approval, and widespread adoption of innovative centesis catheters, driving overall market growth.<\/p>\n
\nThe centesis catheters market is fiercely competitive, dominated by key players such as AngioDynamics, BD, Boston Scientific, Medtronic, and Merit Medical. This competition poses challenges for new entrants aiming to establish market presence. Regulatory complexities, including stringent FDA and CE mark approvals, add to the hurdles, along with significant R&D investments needed for developing innovative catheters. Economic factors like high costs and limited reimbursement in certain regions further constrain market growth, necessitating strategic approaches to navigate these challenges effectively.<\/p>\n
\n\u0095\tIn Feb 2024, AngioDynamics, headquartered in Latham, New York, sold its PICC, midline, and tip location products to Spectrum Vascular for $34.5 million upfront. Spectrum will also pay an additional $5.5 million based on future sales, with AngioDynamics receiving a $5 million milestone payment upon transferring production to a third-party manufacturer.
\n\u0095\tIn Sep 2022, B. Braun Medical Inc. acquired the Clik-FIX catheter securement device portfolio from Starboard Medical, Inc. This acquisition enhances B. Braun’s commitment to innovation in peripheral intravenous (IV) therapy, aiming to improve patient experience and outcomes.<\/p>\n
\n\u0095\tSmall-Bore Centesis Catheters
\n\u0095\tLarge-Bore Centesis Catheters <\/p>\n
\n\u0095\tParacentesis
\n\u0095\tThoracentesis
\n\u0095\tArthrocentesis
\n\u0095\tAmniocentesis
\n\u0095\tOther Centesis Procedures<\/p>\n
\n\u0095\tDiagnostic Applications
\n\u0095\tTherapeutic Applications
\n\u0095\tPalliative Care Applications<\/p>\n
\n\u0095\tHospitals
\n\u0095\tAmbulatory Surgical Centers
\n\u0095\tOther End Use<\/p>\n
\nNorth America-
\n\u0095\tThe US
\n\u0095\tCanada
\n\u0095\tMexico
\nEurope-
\n\u0095\tGermany
\n\u0095\tThe UK
\n\u0095\tFrance
\n\u0095\tItaly
\n\u0095\tSpain
\n\u0095\tRest of Europe
\nAsia-Pacific-
\n\u0095\tChina
\n\u0095\tJapan
\n\u0095\tIndia
\n\u0095\tSouth Korea
\n\u0095\tSoutheast Asia
\n\u0095\tRest of Asia Pacific
\nLatin America-
\n\u0095\tBrazil
\n\u0095\tArgentina
\n\u0095\tRest of Latin America
\n Middle East & Africa-
\n\u0095\tGCC Countries
\n\u0095\tSouth Africa
\n\u0095\tRest of Middle East and Africa<\/p>\n